Stockscreener 앱 받기
243.00
1.68%
-4.16
시간 외 거래:
243.00
전일 마감가:
$247.16
열려 있는:
$245
하루 거래량:
328.11K
Relative Volume:
1.26
시가총액:
$6.81B
수익:
$2.58B
순이익/손실:
$-778.69M
주가수익비율:
-8.8913
EPS:
-27.33
순현금흐름:
$223.75M
1주 성능:
-5.33%
1개월 성능:
-8.52%
6개월 성능:
-26.76%
1년 성능:
-29.74%
1일 변동 폭
$241.87
$246.81
1주일 범위
$241.87
$259.95
52주 변동 폭
$241.87
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
BIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
243.00 | 6.81B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
130.82 | 226.88B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.36 | 146.96B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.63 | 112.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Jefferies cuts Bio-Rad Labs target to $285, maintains Hold By Investing.com - Investing.com Canada
Life Science Products Market Projected To Witness Substantial - openPR
HIV Diagnostics Test Market Projected To Witness Substantial - openPR
Cancer Biomarkers Market: Emerging Trends, Growth Drivers & - openPR
Bio-Rad stock touches 52-week low at $243.94 amid market shifts By Investing.com - Investing.com South Africa
Bio-Rad stock touches 52-week low at $243.94 amid market shifts - Investing.com Australia
Chromatography Data System Market Generated Opportunities, - openPR
High End Cellomics Market Set to Witness Significant Growth - openPR
Flow Cytometry Market Is Booming Worldwide | Luminex - openPR
Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund - MSN
Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed - MSN
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts -March 24, 2025 at 04:06 pm EDT - Marketscreener.com
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts - StreetInsider.com
Oncocyte Secures Game-Changing Bio-Rad Deal and $57M War Chest for $1B Market Push - StockTitan
Clinical Diagnostics Market is Projected to Increase at a CAGR - openPR
Monoclonal Antibody Diagnostic Reagents Market Growth - openPR
Oncocyte secures $29.1 million to advance FDA assay - MSN
Bio-Rad Launches XP-Design Assay Salmonella Serotyping Solution for Food Safety Testing - Technology Networks
Enzyme Linked Immunosorbent Assay Market Growth Analysis: - openPR
South East Asia And South Asia Industrial Microbiology Market - openPR
Life Science Products Market Is Booming Worldwide 2025-2032 | - openPR
Hemoglobin A1c Testing Devices Market Projected To Witness - openPR
Learn to Evaluate (BIO) using the Charts - Stock Traders Daily
Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? - Simply Wall St
Cancer Biomarkers Market Size, Share, Growth Factors, - openPR
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Blotting Machine Market Future Business Opportunities - openPR
Where are the Opportunities in (BIO.B) - Stock Traders Daily
The Future of Genetic Testing: Industry Growth, Trends & Key - openPR
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Bio-Rad Laboratories, - EIN News
Transcriptomics Technologies Market Future Business - openPR
Salmonella serotyping solution enhances food safety testing - Labmate Online
New XP-Design Assay Salmonella Serotyping Solution for Rapid, Accurate Food Safety Testing - Food Safety Magazine
Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing - Cambridge Network
Newborn Screening Market Growth in Future Scope 2025-2032 | - openPR
Charles Schwab Investment Management Inc. Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Laboratory Supplies Market Generated Opportunities, Future - openPR
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
ChemiDoc Go Imaging System - The Scientist
HIV Rapid Test Kits Market Focused Insights 2025-2030: Abbott, Bio-Rad, and bioMerieux Strengthen Market Position Amid Rising Competition - Yahoo Finance
Stem Cell Assay Market Demand, Industry Growth and Future Scope - openPR
Empowering Growth: Vector Purification Market 2025 - openPR
Clinical Biomarkers Market Key Players Analysis- Johnson & - openPR
Expanded kit range enhances AAV vector characterisation - Labmate Online
Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire
Neurological Biomarkers: Global Market Review 2020-2024 and Forecast to 2030, Featuring Analysis of PerkinElmer, Abbott Labs, Thermo Fisher Scientific, Banyan Biomarkers, Bio-Rad Labs & More - Yahoo Finance
High-Performance Liquid Chromatography Market Top Players - openPR
Genomics Market Expansion | Future Trends & Investment Insights - openPR
Bio-Rad stock touches 52-week low at $248.05 amid market shifts - Investing.com Australia
Bio-Rad stock touches 52-week low at $248.05 amid market shifts By Investing.com - Investing.com South Africa
Cancer Monoclonal Antibodies Market Is Booming Worldwide | Abnova Corporation, BioGenex, Bio-Rad Laboratories - openPR
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
0.10%
자본화:
|
볼륨(24시간):